Table Of Content

Molecular and Cellular Endocrinology, 91 (1993) 219-223 © 1993 Elsevier Scientific Publishers Ireland, Ltd. 0303-/7932 /0$067.0 0 Key Word Index to Volumes 83-90 (1993) Acidic epididymal glycoprotein, (89) 25 Anti-T, receptor antibody, (84) 159 Calcium uptake, (84) 15 Acromegaly, (85) 157 Apoptosis, (84) C19 Calmodulin, (84) 227 ACTH, (89) 39 Apotransferrin, (83) 239 Calmodulin binding, (84) 15 Actin, (86) 119 Arachidonic acid, (83) 173, (84) 155 Ca mobilization, (83) 173 B-Actin, (87) R7 Arginine, (84) R1 Carbachol, (86) 93 Activin, (83) 105 Arginine vasopressin, (87) 35 Carbohydrate epitope, (86) 57 Activin-binding protein, (90) 1 Aromatase cytochrome P-450, (85) 205 Carboxypeptidase H, (86) 221 Activin receptor, (83) R1 Arrestin, (84) R39 Cardiac muscle, (87) 87 Adenohypophyseal mRNA, (84) 55 Aspartate aminotransferase, (90) 27 Casein secretion, (84) 155 Adenohypophysis, (85) C45 Atlantic salmon, (84) 167 Castration, (89) 67 Adenylate cyclase, (83) 201, (85) 53, (86) 213 Atopy, (83) C9 C-cell, (86) 213 Adenylate cyclase (ovine), (88) 111 ATP, (88) 129 cde2, (87) 179 Adenylyl cyclase, (85) 195, (90) 203 Atresia, (84) C19 Cell culture, (84) 109, (86) 73, (87) 105, (87) Adipocyte, (84) 65, (85) 13, (85) 73 Atrial natriuretic peptide, (89) 39 R11, (88) 97 Adipose tissue metabolism, (85) 13 Atrial peptide hormone, (90) 47 Cell differentiation, (88) 47 Adrenal, (83) 29, (87) R1 Autoantibody, (88) 89 Cell growth, (86) 11 Adrenai glomerulosa, (90) 53 Autocrine regulation, (85) 65 Cell growth, pituitary tumor cell, (83) 239 a,-Adrenergic agonist, (90) 87 Autocrine system, (89) 59 Cell line, (84) 203 B-Adrenergic agonist, (87) 29 Autoinduction, (87) 105 Cell-plating density, (90) 157 a-Adrenergic receptor, (84) 33 Autoradiography, (85) 157 Cell proliferation, (83) 73, (90) 231 a-Adrenergic receptor blocker, (88) 129 Autoregulation, (83) Cl Cell receptor, (89) 33 Adrenoceptor, (86) 73 Cell-specific gene expression, (89) 153 Adrenocortical cell, (89) 19 Baculovirus, (83) 117 Characterization, (84) 1 Adrenocorticotropin, (87) 35 Basic fibroblast growth factor, (88) 39, (89) Chemotactic activity, (84) 47 AF-DX-116, (90) 87 163 Chinese hamster ovary cells, (83) 153 Albumin, (83) 85, (85) 165 Benzodiazepine, (87) R1 Chloramphenicol acetyltransferase assay, (84) Alcohol dehydrogenase, (86) 187 Benzodiazepine receptors, (88) 1 209 Aldosterone, (83) 57, (90) 53, (90) CS Binding inhibitor, (87) 115 Chloramphenicol acetyl transferase, (87) 147 Aldosterone secretion, (86) 93 Binding protein, (88) Cl Chloride channel, (88) 105 Alkylation, (85) 53 Biosynthesis, (84) 119, (89) 111, (89) 127 Chloride flux, (90) C11 Allatostatin, (89) 121 Biphasic dose-response curve, (90) C1 CHO cell, (86) 37, (87) 147 Alpha subunit, (85) 41 Bombesin, (85) 215 Cholesterol side-chain cleavage enzyme, (87) Alternative promoter, (83) R9 Bone, (90) 197 57 Alternative splicing, (83) 21, (84) 127, (90) 171 Breast cancer, (83) 85, (85) 83, (85) 165, (90) Choriocarcinoma cell line (JAR), (87) 139 Amino acid sequence, (85) 127, (85) 141 77 Chorionic gonadotrophin hormone, (85) 65, Amylin, (84) R1 Breast cancer cell, (85) 215 (86) Cl Androgen, (84) 145, (86) 111, (88) 153, (89) Brown adipocyte, (86) 73 Chromogranin A, (88) 97 67, (89) 153, (90) 219 Brown adipose tissue, (89) 11 '25]-d(CH 5)<[TyTrhr*(, TMyre-N)H $?]-,OV T Androgen action, (87) R25 binding, (86) 193 Androgen and estrogen antagonism, (86) 187 Ca?*+-ATPase mRNA, (90) 125 Citrate, (90) 27 Androgen-binding protein, (89) 33 Calbindin, (86) 119 C-kinase, (86) 157 Androgen metabolism, (87) R25 Calbindin-Dj.,, (83) 143, (86) 83 Clonidine, (84) 33 Androgen receptor, (88) 15, (88) 77, (88) 153, Calbindin-Dg,, (88) 119 Clusterin, (89) 127 (88) 165, (90) 219, (90) R11 Calcitonin, (85) 65 Collagenase inhibitor, (83) 65 Androgen-regulated protein, (83) 219 Calcitonin gene-related peptide [8-37], (84) Collecting ducts, (86) 193 Anestrus, (85) 205 Rl Colon rat, (85) 21 Angiogenesis, (84) 47 Calcitonin secretion, (86) 213 Confocal microscopy, (87) R1 Angiotensin II, (83) 57, (86) 93, (90) 53 Calcium, (83) 79, (84) 137, (84) 227, (86) 137, Conformation, (85) 227 Angiotensin II receptor subtype, (90) 53 (87) 29, (87) 49, (87) 157, (88) 129, (89) Corpora allata, (84) 227, (89) 121 Anion exchange, (90) 95 111, (90) 197 Corpuscles of Stannius, (90) 179 Antagonistic activity, (85) 227 Calcium antagonist, (84) 227 Corpus luteum, (85) 33, (85) 195, (87) 115, Anterior pituitary, ovine, (87) 35 Calcium channel, (90) 231 (89) RS Antibody, (85) 21 Calcium, extracellular, (90) 165 Cortex, (83) 29 Antibody, polyclonal, (86) 57 Calcium flux, (86) 21 Cortisol, (83) C13 Anti-estrogen, (90) 77 Calcium imaging, (86) 167 Cortisone, (83) C13 Anti-peptide antibody, (85) 89, (87) 9 Calcium ionophore, (85) 237 Cross-talk, (90) 87 220 C-terminus, (86) 221 Epitope, (85) 41 Glomerulosa cell, (86) 93 Cyclic AMP, (84) 15, (84) 195, (85) 65, (85) Estradiol, (83) 85, (84) 23, (84) 55, (84) 109, Glucagon-like peptide-1, (85) C39 175, (86) 29, (87) 69, (87) 79, (88) 105, (88) (87) 95, (88) 97 Glucocorticoid, (84) 39, (84) 65, (90) 141, (90) R1, (89) 97, (89) 121, (90) 53, (90) 141, (90) 17B-Estradiol, (90) 133 203 231 Estradiol 17B-dehydrogenase, (85) 165 Glucocorticoid physiology, (90) C1 Cyclic AMP-dependent protein kinase, (83) Estradiol 178-hydroxysteroid dehydrogenase, Glucocorticoid receptor, (90) R11 11, (85) 195, (90) 187 (83) 85 Glucocorticoid receptor (human), (83) 153 Cyclic AMP induction, (89) 141 Estradiol receptor, (90) 133 Glucose, (84) R1 Cyclic GMP, (89) 39, (89) 121, (90) R1 Estrogen, (84) 175, (85) 13, (85) 165, (86) 119, Glucose transport, (87) 131 Cyclic nucleotide, (90) 47 (87) R11, (88) 67, (90) 77, (90) 171, (90) B-Glucuronidase, (86) 187 Cytochrome oxidase, (86) 143 C15, (90) R17 Glutamine synthetase, (83) 117 Cytochrome P-450,..., (87) 57 Estrogen induction, (87) 179 Glycerol phosphate shuttle, (83) 95 Cytokine, (87) R19 Estrogen receptor, (85) 83, (90) 77 Glycoprotein hormone, (83) 195, (89) 153 Cytoplasmic Ca?*, (83) 211 Estrogen regulation, (86) 1 Glycosylation, (85) 227, (89) 111 Cytosolic calcium, (86) 167, (86) 213 Estrone, (83) 85 Gonadotropes, (87) 95 Estrous cycle, (86) 119 Gonadotropin, (85) 127, (85) 175, (85) 183, Deletion, (84) R23 Expression, (84) 1, (89) 105 (86) C1, (86) 205, (88) 143, (90) 17 Desensitization, (83) C1 Gonadotropin B-subunit mutant, (90) 211 Desmolase, (84) 195 Fast skeletal muscle, (90) 125 Gonadotropin receptors, (87) R25 Development, (84) 55 Feeder, (84) R15 Gonadotropin-releasing hormone, (84) 137, Developmental regulation, (89) 105 Fertilization, in vitro, (88) 135, (90) 157 (84) 167, (84) C33, (85) 175, (86) 1, (86) Dexamethasone, (83) 183 Fetus, (89) 47 167, (87) 95, (89) 111 Diabetes mellitus, (86) 149 Fibroblast growth factor, (84) 109, (84) R15 Gonadotropin-releasing hormone-associated Diabetes mellitus, experimental, (86) 67 Filamentous staining, (86) 83 peptide, (84) 167 Diacylglycerol, (83) 57, (86) 93 Fish, (85) 175, (87) R7 Gonadotropin-releasing hormone receptor, Dibutyryl-cylic AMP, (88) 153 Follicle, (90) 39 (85) 109, (90) RS Diferric transferrin, (83) 239 Follicle-stimulating hormone, (85) 99, (86) C1, G protein, (85) 53, (86) 213, (90) 203 Differential screening, (83) 65 (88) 67, (88) 153, (89) R1 G protein-coupled receptor, (90) R5 Dihydrotestosterone, (88) 67, (90) 219 Follicle-stimulating hormone-8, human, (85) Granular convoluted tubule, (89) 25 5a-Dihydrotestosterone, (88) 15 89 Granulosa cell, (83) 73, (83) 173, (84) 47, (84) 1,25-Dihydroxycholecalciferol, (86) 21 Follicle-stimulating hormone binding, stabi- 137, (84) R7, (87) 115, (88) 47, (89) 97, (90) 1,25-Dihydroxyvitamin D;, (83) C9, (84) 15, lization, (87) 49 17, (90) 39 (84) 99, (90) 197, (90) 231 Follicle-stimulating hormone receptor mRNA, Granulosa-lutein cell, (90) 157 Direct repeats, (83) 21 (84) R45, (88) 55, (89) 141 Growth factor, (84) R15, (85) 165, (87) R25 cDNA, (89) 47 Follicle-stimulating hormone-responsive, (89) Growth hormone, (83) 39, (87) 1, (87) R7 DNA-binding domain, (90) R11 141 Growth hormone- and growth hormone /pro- DNA binding domain protein, (84) 209 Follicular development, (84) R7 lactin-secreting (human pituitary) tumors, DNA-binding protein, (90) 17 Folliculo-stellatae cells, (85) 1 (87) 125 cDNA cloning, (90) R17 Follitropin, (85) 41 Growth hormone receptor, (83) 133, (86) 37, cDNA isolation, (89) 105 Follitropin receptor, (87) 9 (89) 47, (89) 91, (90) 103 cDNA library, (83) 65 Fos, (87) 179 Growth hormone releasing factor, (83) 73 cDNA sequence, (87) R19 FRTLS cell, (86) 11 GSP oncogene, (87) 125 cDNA sequencing, (90) 7 Functional expression, (86) 37 DNA synthesis, (89) 97 Fura-2, (86) 167, (89) 79 Harderian gland frog, (84) R51 Down-regulation, (83) Cl Fusion protein, (85) 21 HC11 cells, (87) 147 Dynorphin, (88) 67 Heat shock 90, (84) 175 Ganglioside GM3, (88) 47 a-Hemoglobin, (84) R27 Early gene, (90) R17 Gastric inhibitory peptide, (90) 117 Heparin binding, (84) R15 Ecdysteroid, (83) 11, (90) 187 G-binding protein, (85) 109 Hepatocyte, (84) 119 Electrical activity, (90) 117 Gel retardation, (88) 175 HEp-2 larynx carcinoma, (86) 111 Elongate spermatid, (83) 219 Gel retardation assay, (84) 209 Hereditary rickets, (90) 197 Embryo, (90) 69 Gene amplification, (83) 117 B-Hexosaminidase, (90) 147 Endocrine system, (88) 1 Gene assembly, (83) 195 Hexose transport, (83) 95 Endometrium, (84) 203, (87) R11, (90) R17 Gene expression, (84) 39, (84) 89, (86) R1, High-performance liquid chromatography, Endonucleasis, (84) C19 (88) 119, (89) 19, (89) 67, (89) R5, (90) 33, (86) 177 Endothelin-1, (84) 203, (89) 1 (90) R23 Homeostasis, (90) C1 Enhanced chemiluminescence, (84) 175 Gene expression, c-erbA, (84) 219 Hormone binding, (87) 9 Enhancer, (88) 31 Generalized resistance to thyroid hormone, Hormone release, (84) C33 Entero-insular axis, (85) C39 (84) 159 Hormonogenic site, (88) 89 Enzyme, (83) C13 Gene regulation, (87) R11, (90) R17 HSP90, (88) 165 Enzyme-linked immunosorbent assay, (85) 89 Gene structure, (88) 55 [*H]Thymidine incorporation, (87) 179 Enzyme superfamily, (84) C25 Genetics, (87) R25 Human androgen receptor fusion protein, (84) Epidermal growth factor, (84) 109, (84) 119, Genistein, (83) 51 1 (84) 195, (88) 135 Germ cell, (83) R1, (84) 79, (89) 127 [>H]Uridine incorporation, (84) R51 Epidermal growth factor receptor, (83) 183 Germ cell depletion, (83) 219 Hybridization, in situ, (84) R45, (89) 153, (90) Epididymal function, (87) R25 G,,, protein, (87) 125 179 Epididymis, (89) 67 GH,C, cell, (87) 29 12-Hydroxyeicosatetraenoic acid (12-HETE), Epinephrine, (85) 73 GH3 cell, (87) 1 (83) 57 118-Hydroxysteroid dehydrogenase, (84) C25 Lactogen, (90) 165 Model system, (84) C33 Hyperosmolarity, (83) 79 Larva, (87) R7 Modulation, (90) C1 Hypothyroidism, (84) 55 Leucine zipper, (84) 209 Modulator, (84) C33, (86) 125 Leydig cell, (83) 105, (83) 125, (83) R1, (84) Molecular cloning, (90) 7 Immunocytochemistry, (84) 175, (85) 1, (87) 185, (87) 57, (88) 39, (89) 59, (89) 163, (90) Molecular variant, (84) R23 179, (90) 179 47 Molluscan insulin-related peptide, (85) 141 Immunology, (87) R25 Leydig cell tumor, (83) 105 Monoclonal antibody, (88) 89 Incretin, (85) C39 Lidocaine, (87) 157 Monocyte, (83) C9 Inhibin, (83) 105, (83) 125, (87) 167 Ligand, (83) C13 Muscarinic ligand, (90) 87 Inhibin a-subunit, (83) 105 Lipid, (83) 201 Muscle, (90) 231 Inhibition by 2,3,7,8-tetrachlorodibenzo-p-di- Lipid-soluble fraction, (84) 47 Mutagenesis, (84) 73 oxin, (87) 19 Lipoprotein, (83) 125 Myoblast, (90) 231 Inositol, (83) 29 Liver, (86) 143 Inositol lipid, (85) 215 Liver regeneration, (84) 119 Nasal gland, (88) 23 Inositol phosphate, (89) 79, (90) 53 LNCaP cell, (88) 153 Natriuretic peptide, (86) R1 Insulin, (84) 39, (84) 109, (84) 219, (84) R1 Luciferase reporter gene, (88) 55 Neomycin, (83) 211 Insulin action, (86) 111 Luteal cell, (84) R7 Neonate, (90) 125, (90) 203 Insulin gene expression, (85) C39 Luteinizing hormone, (83) 125, (85) 99, (85) Nephron microdissection, (86) 193 Insulin-like growth factor, (83) R17, (84) 195, 117, (86) C1, (87) 57, (87) 115, (88) 67, (89) Nerve growth factor gene expression, (84) 145 (88) 77, (90) 147 59, (89) 111 Neurointermediate lobe, (84) 23 Insulin-like growth factor binding protein-3, Luteinizing hormone /chorionic gonadotropin Neuropeptide, (85) 141 (83) R17, (84) 119 receptor, (84) 127 Neurophysin, (89) 59 Insulin-like growth factor-binding proteins 1 Luteinizing hormone/human chorionic go- Neurotoxin, (84) 155 and 3, (89) R1 nadotropin receptor, (83) 201 Nitric oxide, (90) R1 Insulin-like growth factor binding protein, (90) Luteinizing hormone receptor, (85) 33, (88) 55 NOG-8, (90) 61 39 Luteinizing hormone receptor expression, (88) Non-cAMP second messenger pathway, (84) Insulin-like growth factor-I, (84) 109, (84) 119, 47 185 (84) 219, (86) 205, (87) 57, (89) 91, (89) R1 (Hyp’)Luteinizing hormone-releasing hor- Noncytoplasmic distribution, (86) 83 Insulin-like growth factor-II, (88) 175, (89) mone, (85) 99 Nuclear estrogen receptor binding, (85) 13 105 Luteinizing hormone-releasing hormone, (85) Nuclear run-off transcription, (90) 27 Insulin-like growth factor-I] /m annose-6- 99 Nucleotide sequence, (85) 127 phosphate receptor, (90) 147 Luteinizing hormone-releasing hormone Insulin-like growth factor-I-induced growth, priming, (85) 183 Obesity, (84) 33 (87) 19 Lymphocyte, (90) C5 Ontogenesis, (86) 193 Insulin-like growth factor-I receptor, (90) 69 Lysosomal enzyme, (90) 147 Ontogeny, (83) 39, (83) 133 Insulin-like growth factor receptor, (90) 147 Lysosome, (90) 147 Ontogeny of gene expression, (89) 91 Insulin receptor, (90) 69 Oocyte maturation, (88) 135 Insulin receptor gene, (86) 111 MA-10 cell, (83) 1 Opioid, (88) 67, (90) 165 Insulin release, (86) 49, (90) 117 a>-Macroglobulin, (84) 243, (89) 127 Organoids, (87) 147 Insulin secreting cell line (RINmSF), (88) 129 Mammalian, (85) 99 Ornithine aminotransferase, (90) 171 Insulin secretion, (85) C39, (86) 149 Mammary cancer, (85) 109 Ornithine decarboxylase, (86) 187 Interferon-y, (86) 103 Mammary cell, (84) 155, (90) 61 Ornithine decarboxylase activity, (86) 67 Interferon regulatory factor-1, (86) 103 Mammary gland tissue, (83) 51 Osmolar concentration, (86) 137 Interleukin-2, (86) 103 Mammary tumor, (85) 83 Osteoporosis, (83) C9 Interleukin-6, (84) R31 Manduca sexta, (83) 11 Osteosarcoma cells (rat), (87) 69 Intestinal adaptation, (83) R17 Massive small bowel resection, (83) R17 Ovarian cancer cell, (83) 183 Intracellular calcium, (89) 79 MCF-7 cell, (87) 19, (90) 77 Ovarian follicles, (84) C19 Intracellular pH, (86) 49 MDBK cell, (83) 143 Ovary, (83) 65, (85) 205, (86) 125, (86) 157, Intron, (89) 141 Mechanism, (88) C1 (89) R1 Iodothyronine, (86) 143 Mediator, (84) C33 Ovary, hen, (83) 173 Ion flux, (90) 117 Melatonin, (88) Cl Ovine placental lactogen, (86) 37 Ionophore, (84) 227 Melatonin receptor, (85) 53 Ovulation, (87) 115 Ion transport, (88) 105 Membrane, (89) 33 Oxytocin, (83) 233 Isoform, (84) 127, (86) 157 Membrane form, (86) 221 P-450,,rom: (83) R9 Membrane receptor, (90) C5 Juvenile hormone, (84) 227, (89) 121 Membrane transport, (87) 139 Pachytene spermatocyte, (83) 219 Kallikrein, (90) C15 Messenger RNA, (84) 89 Pancreastatin, (88) 129 Kallikrein, fetal, (88) 23 Metamorphosis, (87) 105 Pancreatectomy, (86) 149 Karyorrhexis, (84) C19 Methotrexate, (83) 153 Pancreatic B-cell, (84) R1 Kidney androgen-regulated protein, (90) 239 Met-Phe, (84) R27 Pancreatic islet, (83) 95, (86) 49, (86) 149, (90) Kidney, bovine, (83) 143 Microsomal membrane, (84) 15 117 Kidney cell, (84) 99 Mineralocorticoid, (90) C11 Pancreatic islets, (86) 149 Kidney, fetal, (88) 23 Mineralocorticoid receptor, (84) C25, (85) 21 Paracrinology, (87) R25 Kidney hypertrophy, (86) 67 Minimal promoter, (90) 33 Parathyroid cell, (83) 211 Mitochondrion, (88) 1 Parathyroid hormone, (87) 69 Lactate transport, (86) 49 Mitogenic activity, (84) 47 Parathyroid hormone release, (83) 211 Lactation, (88) 119 MMTV-CAT reporter gene, (88) 15 Parotid gland, (85) 21 Penis, (90) 219 Progesterone synthesis, (85) 195 Sequences, 5’-untranslated, (90) 103 Peptide, (84) R27, (85) 41 Prohormone, (90) C15 Serine dehydratase, (90) 141 Peptide biosynthesis, (84) 89 Prolactin, (83) 51, (83) 79, (84) 55, (84) 155, Sertoli cell, (83) 105, (83) 219, (83) R1, (84) Peptide synthesis, (86) C1 (86) 103, (87) 1, (87) 29, (87) R19, (89) 1, 79, (84) R45, (87) 167, (88) 153, (89) 127 Peritubular cell, (83) 219 (90) 27, (90) 61, (90) 133, (90) C15 Serum binding protein. (83) 133 Peritubular myoid cell, (88) 153 Prolactin receptor, (89) 47 Sex-hormone-binding globulin, (89) 33 Peroxidase, (84) 73 Prolactin secretion, (86) 137, (87) 157 $14 gene, (84) 65 Pertussis toxin, (86) 213 Proliferation, (87) 69 Short-chain alcohol dehydrogenase, (84) C25 Phagocytosis, (84) R27 Promoter, (88) 55, (88) 175 Signal transduction, (83) 173, (85) 227, (87) Phenotypic switching, (89) 19 Prostaglandin E, formation, (85) 73 69, (87) R25, (90) R1 Phorbol ester, (84) 195, (85) 215, (85) 237 Prostaglandin F,,,, (84) 137 Single-strand conformation polymorphism Phosphatidylinositol 4,5-bisphosphate cas- Prostate, (88) 77, (90) 27 analysis, (87) 125 cade, (88) R1 Protein kinase, (90) 47 Site-directed mutagenesis, (86) C1 Phosphoinositidase C, (83) 29 Protein kinase A, (87) 69, (90) 231 Skeletal muscle, (84) 15, (89) 11 Phosphoinositide turnover, (89) 1 Protein kinase C, (83) 11, (83) 143, (84) C33, [*°S]Methionine incorporation, (84) R51 Phosphoinositols, (83) 29 (85) 183, (85) 237, (86) 125, (86) 137, (90) Smooth muscle, (90) 219 Phospholipase A>, (84) 155, (85) 73 27, (90) 61, (90) 231 S1 nuclease, (86) 177 Phospholipase C, (83) 29, (87) 95 Protein kinase C, activation, (87) 35 Sockeye salmon, (90) 179 Phospholipase C inhibitors, (84) C33 Protein synthesis, (83) 1, (84) 39, (87) 105 Sodium butyrate, (84) 99 Pineal gland, (88) Cl Prothoracic gland, (90) 187 Soluble form, (86) 221 Pituicytes, (85) 1 Prothoracicotropic hormone, (90) 187 Somatomedin, (86) 11 Pituitary, (83) 239, (85) 1, (85) 99, (88) 97, (89) Somatostatin, (86) 213, (88) 111 1, (90) C15 Quantitative polymerase chain reaction, (86) Somatotropin, (84) 23, (85) 157 Pituitary adenylate cyclase polypeptide, (87) R1 Somatotropin-releasing hormone, (85) 157 79 Spermatogenesis, (83) R1, (84) R45 Pituitary cDNA library, (85) 127 Rat growth hormone gene promoter, (84) 209 Spermatogenesis, organization, (87) R25 Pituitary cell, (85) C45 Rb, (87) 179 Spermine, (83) 11 Pituitary cells, dispersed, (84) R31 Receptor, (83) 39, (83) C13, (84) 65, (87) 95, Sperm maturation, (89) 25 Pituitary endocrine cell, (87) 79 (87) R1, (88) 39, (88) 111, (88) C1 Spin label, (83) 201 Pituitary fibroblast, (87) 79 Receptor activity, (84) 99 Spleen cell, (84) R27 Pituitary gland, (89) 39 Receptor binding, (86) C1, (90) 211 Stable expression, (84) 73 Pituitary hormone, (88) 77 Receptor overexpression, (83) 153 Stanniocalcin, (90) 7, (90) 179 Pituitary neoplasm, (85) 157 Receptor regulation, (83) C9 Staphylococcus aureus V8 digestion, (90) 1 Pituitary, rat, (90) RS Receptor subtype, (90) 87 Staurosporine, (85) 183 Placenta, (83) R9, (87) 139, (89) 47, (90) 165 Receptor thyrotropin, human, (83) 117 Steroid, (90) 157 Placental cell expression of gonadotropin-re- Receptor, type I, (85) 21 Steroid 17a-hydroxylase, (89) 19 leasing hormone, (86) 1 Recombinant, (84) 73 Steroidogenesis, (83) 1, (83) 125, (84) 185, (84) Plasma growth hormone and insulin-like Recombinant DNA, (83) 195 243, (85) 227, (87) 57, (87) R1, (89) 79, (90) growth factor-I, (89) 91 Recombinant human choriogonadotropin B- 47, (90) 211 Platelet-derived growth factor, (83) 57, (84) subunit, (86) 57 Steroidogenesis inducing protein, (84) 185, 109 Recombinant human follistatin, (90) 1 (89) 97 Point mutation, (84) 159 Recombinant protein, (83) 117, (89) 141 Steroid production, (84) 185, (85) 117 Polarized secretion, (89) 127 Reconstitution, (83) 201 Steroid receptor, (83) Cl Polyadenylation, (88) 143 Regulation, (90) 133 Steroid receptor, soluble, (84) 1 Poly(A)*-RNA synthesis, (84) R51 Relaxin, (89) R5 Steroid reductase, (84) C25 Poly(A) tail, (86) 29 Responsive element, (90) R11 Stimulation, (86) 125 Polymerase chain reaction, (84) 127, (84) R23, Retina membrane, (88) 111 Streptozotocin, (83) 95 (85) 127, (87) 125 Retinoic acid, (84) 65 Striated skeletal muscle, (87) 87 Polymerase chain reaction amplification, (90) Ricin, (87) 1 Structure-activity relations, (86) C1 103 mRNA, (83) 39, (83) 133, (86) 29, (86) 205, Submandibular gland, (84) 145, (89) 25 Polypeptide epitope, (86) 57 (89) 67, (90) 179 Sulfate uptake, (90) 95 Posttesticular events, (87) R25 RNA blot hybridization, (87) R7 Swiss 3T3 fibroblast, (87) 79 Post-translational maturation, (83) 233 mRNA level, (90) 219 Synthetic peptide, (87) 9 Potassium, (83) 79 mRNA stability, (88) 143 Prazosin, (84) 33, (90) 87 Round spermatids, (83) 219 aT3-1 cell, (86) 167, (87) 95 Pregnancy, (85) 205, (88) 119, (89) R5, (90) T cell activation gene, (86) 103 239 Salivary gland, (88) 23 Testicular cell-cell interaction, (83) 219 Preproenkephalin gene, (84) 79 Salmo salar, (84) 167 Testin, (89) 127 Preproinsulin mRNAs, (86) 177 Sarcoplasmic endoplasmic reticulum Ca?* Testis, (87) R25 Preprotachykinin, (84) 55 ATPase mRNA, (87) 87 Testosterone, (83) 219, (84) R27, (84) R51, Primary culture, (83) 125 Sarcoplasmic reticulum, (90) 125 (88) 15, (89) 163 Pro-aC, (85) 237 Second messenger, (84) C33, (89) 121 12-O-Tetradecanoylphorbol 13-acetate, (83) Procaine, (87) 157 Secretion, (83) 79, (86) 29 143, (86) 29 Processing, (90) C15 Secretogranin II, (88) 97 Theca cell, (90) 39 Progesterone, (83) 73, (85) 33, (85) 117, (88) Seminiferous tubule, (83) 219 Thecal cell, porcine, (85) 117 67, (88) 135, (90) 95 Senescence, (89) 19 Thecal-interstitial cell, (84) R7 Progesterone secretion, (89) 141 Sequence, (83) 85 Thiol-disulfide exchange, (85) 1 Thymidine incorporation, (84) 109 Topography, (85) 89 Uncoupling protein, (86) 73 Thymocyte, (87) R19 Transcription, (84) 39, (84) 65, (86) 187, (88) Urinary electrolyte ratio, (90) C11 Thyroglobulin, (88) 31, (88) 89, (90) R23 15, (88) 31, (88) 153 Uterus, (84) 109, (86) 119, (87) R11, (90) 239 Thyroglobulin gene, (84) R23, (90) 33 Transcriptional regulation, (90) 111, (90) 141 Thyroglobulin mRNA, (84) R23 Transcription control, (90) R23 Variable number of tandem repeats (VNTR), Thyroid, (84) 73, (84) R15, (86) 11, (88) 31, Transcription initiation site, (88) 55 (83) 21 (88) 105, (90) R1, (90) R23 Transcription, in vitro, (88) 175 Vasoactive intestinal peptide, (83) 73, (84) 89, Thyroid cDNA library, (84) R39 Transdifferentiation, (84) 23 (87) 1 Thyroid FRTL-5 cell, (84) 219, (86) 21 Transduction, (85) 175 Vasopressin, (86) 29, (89) 59 Thyroid hormone, (83) 239, (84) 145, (87) 131, Transfection, (87) 147, (87) R11, (89) 19 Vasopressin analogues, (86) 193 (87) 139, (88) 89, (90) 111, (90) 125 Transforming growth factor-B, (84) 243, (85) Vasopressin mRNA, (89) 59 Thyroid hormone receptor, (84) 209, (87) 105 117, (89) 97 Thyroid hormone resistance, (90) 111 Transforming growth factor-B,, -B>, (84) R7 Vitamin D receptor, (83) 143 Vitamin D resistance, (90) 197 Thyroid hormone response element, (84) 209 Transgenic mice, (90) 33 Vitamin D-resistant rickets, (83) C9 Thyroid hormone status, changes, (87) 87 Transglutaminase, (87) 49 Thyroid, human, (84) R23 Transient expression, (87) 147 Thyroid peroxidase, (83) 21 Translation, (89) 111, (90) 171 Western blot, (84) 175 Thyroid-stimulating antibody, (88) R1 Translation, in vitro, (88) 165 White adipose tissue, (89) 11 Thyroid-stimulating hormone, (86) Cl T; receptor gene, (84) 159 Thyroid-stimulating hormone receptor, (88) Trophic hormone, (83) 1 Xenopus, (87) 105 R1 Trophoblast cell, (85) 65 Xenopus oocytes expression, (90) RS Thyrotropin, (84) 55, (84) 219, (90) 33 Trophoblastic cell, (90) 165 Thyrotropin-releasing hormone, (87) 1 TTF-1, (88) 31 Tilapia, (85) 175 Tubulin, (86) 83 Y-1 cell, (83) 1 Tissue culture, (84) 89, (86) 149 Tumor necrosis factor-a, (84) R31 Yohimbine, (84) 33 Tyrosine kinase, (83) 51, (90) 69 Molecular and Cellular Endocrinology, 91 (1993) 225-234 © 1993 Elsevier Scientific Publishers Ireland, Ltd. 0303-/7932 /0$067.0 0 Author Index to Volumes 83-90 (1993) Aatsinki, J.T., Pietila, E.M., Lakkakorpi, J.T. Arilla, E., see Colas, B. (88) 111 Bellido, T., Morelli, $., Fernandez, L.M. and and Rajaniemi, H.J. Arinze, I.J., see Kawai, Y. (90) 203 Boland, R. Expression of the LH/CG receptor gene Armstrong, D.T., see Engelhardt, H. (85) 117 Evidence for the participation of protein in rat ovarian tissue is regulated by an Armstrong, J.W., Cragoe, Jr., E.J., Bourke, kinase C and 3’,5’-cyclic AMP-dependent extensive alternative splicing of the pri- J.R., Huxham, G.J. and Manley, S.W. protein kinase in the stimulation of muscle mary transcript (84) 127 Chloride conductance of apical membrane cell proliferation by 1,25-dihydroxy-vita- Abreu, L.C., see Porto, C.S. (89) 33 in cultured porcine thyroid cells activated min D; (90) 231 Adams, T.E., see Fiddes, R.J. (86) 37 by cyclic AMP (88) 105 Bellingham, D.L., Sar, M. and Cidlowski, J.A. Adashi, E.Y., see Hurwitz, A. (84) C19 Audinot, V., see Gautron, J.P. (85) 99 Methotrexate-induced overexpression of Adessi, G.L., see Beck, L. (90) 95 Auersperg, N., see Roskelley, C.D. (89) 79 functional glucocorticoid receptors in Chi- Adessi, G.L., see Pellerin, I. (90) R17 Aumeier, S., see Kessler, U. (90) 147 nese hamster ovary cells (83) 153 Adessi, G.L., see Vuillermoz, C. (87) R11 Bello, P.A., see Nash, A.D. (84) R31 Aflalo, L., see Sakal, E. (90) 39 Ben-Yosef, D., Galiani, D., Dekel, N. and Aguilera, G. Baarends, W.M., see Blok, L.J. (88) 153 Shalgi, R. Role of angiotensin II receptor subtypes Baas, F., see Bikker, H. (83) 21 Rat oocytes induced to mature by epider- on the regulation of aldosterone secretion Bahl, O.P., see Chen, W. (86) 57 mal growth factor are successfully fertil- in the adrenal glomerulosa zone in the rat Bailbe, D., see Giroix, M.-H. (83) 95 ized (88) 135 (90) 53 Baimbridge, K.G., see Rodway, M.R. (84) 137 Benahmed, M., see Sordoillet, C. (89) 163 Ahima, R., see Krozowski, Z. (85) 21 Baimbridge, K.G., see Roskelley, C.D. (89) 79 Benedetti Panici, P., see Ferrandina, G. (83) Akerstrém, G., see Ridefelt, P. (83) 211 Banerjee, R. and Vonderhaar, B.K. 183 Al-Ageel, A., see Wiese, R.J. (90) 197 Prolactin-induced protein kinase C activity Benne, F., see Hatey, F. (86) 205 Albiston, A.L., Taylor, R.G., Herington, A.C., in a mouse mammary cell line (NOG-8) Benoit, S.E., see Jonassen, J.A. (84) 55 Beveridge, D.J. and Fuller, P.J. (90) 61 Best, L., Trebilecck, R. and Tomlinson, S. Divergent ileal IGF-I and IGFBP-3 gene Bar-Ami, S. and Gitay-Goren, H. Lactate transport in insulin-secreting B- expression after small bowel resection: a Altered steroidogenic activity of human cells: contrast between rat islets and HIT- novel mechanism to amplify IGF action? granulosa-lutein cells at different cell den- T15 insulinoma cells (86) 49 (83) R17 sities in culture (90) 157 Beveridge, D.J., see Albiston, A.L. (83) R17 Alestrom, P., see Klungland, H. (84) 167 Bar-Ami, S., see Gavish, M. (88) 1 Biegel, L., see Liu, H. (87) 19 Allen, C.U., Janzen, W.P. and Granger, N.A. Barcena, J.A., see Padilla, C.A. (85) 1 Bikker, H., Baas, F. and De Vijlder, J.J.M. Manipulation of intracellular calcium af- Bardin, C.W., see Fujisawa, M. (84) 79 Structure and characterization of a 50 bp fects in vitro juvenile hormone synthesis Bardin, C.W., see Grima, J. (89) 127 repeat in intron 10 of the human thyroid by larval corpora allata of Manduca sexta Bardin, C.W., see Porto, C.S. (89) 33 peroxidase gene (83) 21 (84) 227 Barnett, R.W., see Campbell, R.K. (83) 195 Bird, I.M., Williams, B.C. and Walker, S.W. Alpizar, E., see Spicer, L.J. (83) 73 Barre, N., see Guillou, M.D. (83) 233 Identification and metabolism of phospho- Ammar, A., Roseau, S. and Butlen, D. Barreca, A., Voci, A., Minuto, F., De Marchis, inositol species formed on angiotensin II Postnatal ontogenesis of vasopressin re- M., Cecchelli, E., Fugassa, E., Giordano, stimulation of zona fasciculata-reticularis ceptors in the rat collecting duct (86) 193 G. and Gallo, G. cells from the bovine adrenal cortex (83) Ammon, H.P.T., see Wahl, M.A. (90) 117 Effect of epidermal growth factor on in- 29 Andersen, @., see Klungland, H. (84) 167 sulin-like growth factor-I (IGF-I) and Bjornsson, B.T., see Le Goff, P. (90) 133 Anderson, L., Hoyland, J., Mason, W.T. and IGF-binding protein synthesis by adult rat Black, M.A., Lefebvre, F.-A., Pope, L., Lefeb- Eidne, K.A. hepatocytes (84) 119 vre, Y.A. and Walker, P. Characterization of the gonadotrophin-re- Barrett, P.Q., see Bollag, W.B. (86) 93 Thyroid hormone and androgen regula- leasing hormone calcium response in sin- Bassas, L., see Girbau, M. (90) 69 tion of nerve growth factor gene expres- gle aT3-1 pituitary gonadotroph cells (86) Bdolah, A., see Lewy, H. (89) 1 sion in the mouse submandibular gland 167 Beck, C.A. and Garner, C.W. (84) 145 Anderson, L., see Eidne, K.A. (90) RS Stimulation of DNA synthesis in rat uter- Blench, I., see Singh, A. (83) 85 Andoh, N., see Tanaka, T. (83) 65 ine cells by growth factors and uterine Blench, I., see Singh, A. (85) 165 Anouar, Y. and Duval, J. extracts (84) 109 Blok, L.J.. Themmen, A.P.N., Peters, Direct estradiol down-regulation of secre- Beck, L., Mahfoudi, A., Mularoni, A., Nicol- A.H.F.M., Trapman, J., Baarends, W.M., togranin II and chromogranin A mRNA lier, M. and Adessi, G.L. Hoogerbrugge, J.W. and Grootegoed, J.A. levels in rat pituitary cells (88) 97 Progesterone stimulates sulfate uptake in Transcriptional regulation of androgen re- Apfelbaum, M.E. subcultured endometrial epithelial cells ceptor gene expression in Sertoli cells and Basal and gonadotrophin-releasing hor- (90) 95 other cell types (88) 153 mone-induced biosynthesis and release of Behre, H.M., see Nieschlag, E. (87) R25 Blok, L.J., see Klaij, I1.A. (85) 237 luteinizing hormone: effect of calcium de- Bélisle, S., see Petit, A. (90) 165 Bluet-Pajot, M.T., see Gautron, J.P. (85) 99 privation (89) 111 Bellabarba, D., see Petit, A. (90) 165 Boland, R., see Bellido, T. (90) 231 226 Boland, R., see Massheimer, V. (84) 15 Champigny, O., Holloway, B.R. and Ricquier, Costello, L.C., see Franklin, R.B. (90) 27 Bollag, W.B., Barrett, P.Q., Isales, C.M., Lis- D. Counis, R., see Bouamoud, N. (88) 143 covitch, M. and Rasmussen, H. Regulation of UCP gene expression in Couper, G., see Eidne, K.A. (90) R5 Signal transduction mechanisms involved brown adipocytes differentiated in pri- Crabbé, J. in carbachol-induced aldosterone secre- mary culture. Effects of a new B-adreno- Aldosterone action, and the cost of flame tion from bovine adrenal glomerulosa cells ceptor agonist (86) 73 photometry (90) C11 (86) 93 Chan, C.B. and MacPhail, R.M. Cragoe, Jr., E.J., see Armstrong, J.W. (88) Bon, C., see Ollivier-Bousquet, M. (84) 155 Functional characterization of a-adreno- 105 Bonanno, G., see Ferrandina, G. (83) 183 ceptors on pancreatic islets of fa/fa Cramb, G., see Gilkes, A.F. (89) 39 Bond, J.A., Graham, G.J., Freshney, M., Zucker rats (84) 33 Currie, W.D., see Krisinger, J. (86) 119 Dawson, T., Sawhney, N., Williams, E.D. Chang, C., see Jiang, S.-Y. (90) 77 Cusson, M., Yagi, K.J., Xue-Chen, G. and and Wynford-Thomas, D. Chang, R., see Wolfe, M.M. (84) 89 Tobe, S.S. Detection and partial purification of a po- Chappel, S.C., see Kelton, C.A. (89) 141 Assessment of the role of cyclic nu- tent mitogenic factor for human thyroid Chari, S., Kail, W., Daume, E. and Sturm, G. cleotides in allatostatin-induced inhibition follicular cells (84) R15 Isolation of luteinising hormone receptor of juvenile hormone biosynthesis in Bonnet, A., see Hatey, F. (86) 205 binding inhibitor from bovine corpus lu- Diploptera punctata (89) 121 Bonnet, P., see Reiter, E. (88) 77 teum (87) 115 Cwyfan-Hughes, S.C., see Mason, H.D. (89) Boockfor, F.R., see Mogg, R.J. (87) 1 Chauvin, M.A., see Sordoillet, C. (89) 163 R1 Borboni, P., see Sesti, G. (86) 111 Chazenbalk, G.D., see Rapoport, B. (84) R39 Borglum, J.D., see Pedersen, $.B. (85) 13 Chen, F., see Huang, J. (90) 211 Borglum, J.D., see Richelsen, B. (85) 73 Chen, W. and Bahl, O.P. Bortoff, K.D. and Messina, J.L. Polyclonal antibodies against the polypep- Dann, J.L., see Krisinger, J. (86) 119 Protein synthesis and insulin regulation of tide and carbohydrate epitopes of recom- Dann, J.L., see Krisinger, J. (88) 119 p33 and PEPCK gene expression (84) 39 binant human choriogonadotropin B-sub- D’Armiento, M., see Ulisse, S. (87) 131 Bouamoud, N., Lerrant, Y., Ribot, G. and unit (86) 57 Dattatreyamurty, B. and Reichert, Jr., L.E. Counis, R. Cheng, C.Y., see Grima, J. (89) 127 A synthetic peptide corresponding to Differential stability of mRNAs coding for Cheng, S.V.Y., see Kelton, C.A. (89) 141 amino acids 9-30 of the extrace'lular do- a and gonadotropin 6 subunits in cul- Chernov, B.K., see Pekhletsky, R.I. (90) 103 main of the follitropin (FSH) receptor tured rat pituitary cells (88) 143 Chieffi-Baccari, G., see Varriale, B. (84) R51 specifically binds FSH (87) 9 Bourke, J.R., see Armstrong, J.W. (88) 105 Chieffi, G., see Varriale, B. (84) R51 Daume, E., see Chari, S. (87) 115 Brandon, M.R., see Fiddes, R.J. (86) 37 Christ, M., see Wehling, M. (90) C5 Davie, J.R., see Wagner, G.F. (90) 7 Brandon, M.R., see Nash, A.D. (84) R31 Christophe, D., see Christophe-Hobertus, C. Dawson, T., see Bond, J.A. (84) R15 Briata, P., see Sesti, G. (86) 111 (88) 31 De Boland, A.R., see Massheimer, V. (84) 15 Bringhurst, F.R., see Zajac, J.D. (87) 69 Christophe, D., see Donda, A. (90) R23 DeGroot, L.J., see Hu, R.M. (84) 209 Brown, A.S., Hall, P.F., Shoyab, M. and Pa- Christophe-Hobertus, C., Donda, A., Javaux, De Jong, F.H., see De Winter, J.P. (83) 105 padopoulos, V. F., Vassart, G. and Christophe, D. De Jong, F.H., see De Winter, J.P. (83) R1 Endozepine/diazepam binding inhibitor Identification of a transcriptional en- De Jong, F.H., see Klaij, I.A. (85) 237 in adrenocortical and Leydig cell lines: hancer upstream from the bovine thy- Dekel, N., see Ben-Yosef, D. (88) 135 absence of hormonal regulation (83) 1 roglobulin gene (88) 31 De Kretser, D.M., see Simpson, B.J.B. (87) Bryant, S.H., see Vakharia, D.D. (85) 89 Cidlowski, J.A., see Bellingham, D.L. (83) 153 167 Burnside, J. and Cogburn, L.A. Cidlowski, J.A., see Burnstein, K.L. (83) Cl De Leval, J., see Reiter, E. (88) 77 Developmental expression of hepatic Cioffi, M., see Lanni, A. (86) 143 DeLuca, H.F., see Wiese, R.J. (90) 197 growth hormone receptor and insulin-like Claessens, F., see De Vos, P. (90) R11 DeManno, D.A., Maizels, E.T. and Hunz- growth factor-I mRNA in the chicken (89) Clamagirand, C., see Guillou, M.D. (83) 233 icker-Dunn, M. 91 Closset, J., see Reiter, E. (88) 77 Hormonal regulation of the type III iso- Burnstein, K.L. and Cidlowski, J.A. Cochaux, P., see Targovnik, H.M. (84) R23 form of C-kinase in porcine ovarian tis- The down side of glucocorticoid receptor Cogburn, L.A., see Burnside, J. (89) 91 sues (86) 157 regulation (83) Cl Coghlan, J.P., see Penschow, J.D. (88) 23 De Marchis, M., see Barreca, A. (84) 119 Bussa, S., see Ferrandina, G. (83) 183 Colas, B., Valencia, A.M., Prieto, J.C. and De Matteis, S., see Ulisse, S. (87) 131 Bussenot, I., see Guillou, M.D. (83) 233 Arilla, E. Demignon, J., see Rebut-Bonneton, C. (85) 65 Butlen, D., see Ammar, A. (86) 193 Somatostatin binding and modulation of De Pablo, F., see Girbau, M. (90) 69 adenylate cyclase in ovine retina mem- De Peretti, E., see Sordoillet, C. (89) 163 branes (88) 111 De Pirro, R., see Sesti, G. (86) 111 Campbell, R.K., Erfle, H., Barnett, R.W. and Collu, R., see Drews, R.T. (87) 125 Deslypere, J.-P., Young, M., Wilson, J.D. and Moyle, W.R. Combest, W.L. and Gilbert, L.I. McPhaul, M.J. Assembly and expression of a synthetic Polyamines modulate multiple protein Testosterone and 5a-dihydrotestosterone gene encoding the bovine glycoprotein phosphorylation pathways in the insect interact differently with the androgen re- hormone a-subunit (83) 195 prothoracic gland (83) 11 ceptor to enhance transcription of the Campbell, R.M., see Spicer, L.J. (83) 73 Conn, P.M., Hawes, B.E. and Janovick, J.A. MMTV-CAT reporter gene (88) 15 Carayon, P., see Mallet, B. (88) 89 Selection of models for the study of GnRH De Vijlder, J.J.M., see Bikker, H. (83) 21 Carlo, P., see Young, A.A. (84) R1 stimulated gonadotropin release preju- De Vincenzo, R., see Ferrandina, G. (83) 183 Catterall, J.F., see Meseguer, A. (89) 153 dices the assignment of roles for media- Devinoy, E., see Pierre, S. (87) 147 Cavari, B., see Funkenstein, B. (87) R7 tors and modulators of hormone action De Vos, P., Claessens, F., Peeters, B., Rom- Cecchelli, E., see Barreca, A. (84) 119 (84) C33 bauts, W., Heyns, W. and Verhoeven, G. Chae, C.-B., see Kamikubo, K. (84) 219 Cooper, T.G., see Nieschlag, E. (87) R25 Interaction of androgen and glucocorti- Chae, C.-B., see Skinner, C.A. (90) 33 Copp, D.H., see Wagner, G.F. (90) 7 coid receptor DNA-binding domains with Chambaz, E.M., see Keramidas, M. (84) 243 Corach, D., see Targovnik, H.M. (84) R23 their response elements (90) R11 227 De Winter, J.P., Themmen, A.P.N., Hooger- Erfle, H., see Campbell, R.K. (83) 195 Fuentes Navarro, A., see Gonzalez-Cadavid, brugge, J.W., Klaij, I.A., Grootegoed, J.A. Eskola, V., see Huhtaniemi, I.T. (88) 55 N.F. (90) 219 and De Jong, F.H. Esteves, R.Z., Van Sande, J. and Dumont, Fugassa, E., see Barreca, A. (84) 119 Activin receptor mRNA expression in rat J.E. Fujisawa, M., Bardin, C.W. and Morris, P.L. testicular cell types (83) R1 Nitric oxide as a signal in thyroid (90) R1 A germ cell factor(s) modulates pre- De Winter, J.P., Timmerman, M.A., Vander- Evain-Brion, D., see Rebut-Bonneton, C. (85) proenkephalin gene expression in rat Ser- stichele, H.M.J., Klaij, I.A., Grootenhuis, 65 toli cells (84) 79 A.J., Rommerts, F.F.G. and De Jong, F.H. Eyster, K.M., Waller, M.S. and Johnson, M.J. Fuller, P.J., see Albiston, A.L. (83) R17 Testicular Leydig cells in vitro secrete only Protein kinase C stimulatory activity in the Funder, J.W., see Liu, J.-P. (87) 35 inhibin a-subunits, whereas Leydig cell tu- pseudopregnant rat ovary (86) 125 Funk, B., see Kessler, U. (90) 147 mors can secrete bioactive inhibin (83) 105 Funkenstein, B., Tandler, A. and Cavari, B. Dias, J.A., see Vakharia, D.D. (85) 89 Developmental expression of the growth Dias, J.A., see Weiner, R.S. (85) 41 hormone gene in the gilthead sea bream Dillmann, W.H., see Sayen, M.R. (87) 87 Fagan, R.J. and Rozen, R. Sparus aurata (87) R7 Di Marino, C., see Veneziani, B.M. (86) 11 Translational control of ornithine-d-ami- Fyhrquist, F., see Pekonen, F. (84) 203 Di Matteo, L., see Varriale, B. (84) R51 notransferase (OAT) by estrogen (90) 171 Dimattia, G.E., see Wagner, G.F. (90) 7 Fan, G. and Rillema, J.A. Gagnon, A.M., see Simboli-Campbell, M. (83) D’Istria, M., see Varriale, B. (84) R51 Effect of a tyrosine kinase inhibitor, genis- 143 Dombrowicz, D., see Reiter, E. (88) 77 tein, on the actions of prolactin in cul- Galiani, D., see Ben-Yosef, D. (88) 135 Donda, A., Javaux, F., Van Renterghem, P., tured mouse mammary tissues (83) 51 Gallo, G., see Barreca, A. (84) 119 Gervy-Decoster, C., Vassart, G. and Faure, J., see Rigaudiére, N. (89) 67 Gallo-Payet, N., see Petit, A. (90) 165 Christophe, D. Fehmann, H.-C., Goke, R. and Goke, B. Galron, R., see Lewy, H. (89) 1 Human, bovine, canine and rat thyroglob- Glucagon-like peptide-1(7-37)/(7-36) Garner, C.W., see Beck, C.A. (84) 109 ulin promoter sequences display species- amide is a new incretin (85) C39 Gasser, F., see Hatey, F. (86) 205 specific differences in an in vitro study Feige, J.-J., see Keramidas, M. (84) 243 Gautron, J.P., Leblanc, P., Bluet-Pajot, M.T., (90) R23 Feige, J.J., see Sordoillet, C. (89) 163 Pattou, E., L’Héritier, A., Mounier, F., Donda, A., see Christophe-Hobertus, C. (88) Fernandez, L.M., see Bellido, T. (90) 231 Ponce, G., Audinot, V., Rasolonjanahary, 31 Fernandez, L.M., see Massheimer, V. (84) 15 R. and Kordon, C. Dorrington, J.H., see Khan, S.A. (89) 97 Ferrandina, G., Scambia, G., Benedetti Pa- A second endogenous molecular form of Dorrington, J.H., see Teerds, K.J. (84) R7 nici, P., Bonanno, G., De Vincenzo, R., mammalian hypothalamic luteinizing hor- Drews, R.T., Gravel, R.A. and Collu, R. Rumi, C., Bussa, S., Genuardi, M., mone-releasing hormone (LHRH), (hy- Identification of G protein a subunit mu- Spica Romano, V. and Mancuso, S. droxyproline’)LHRH, releases luteinizing tations in human growth hormone (GH)- Effects of dexamethasone on the growth hormone and _follicle-stimulating hor- and GH/prolactin-secreting pituitary tu- and epidermal growth factor receptor ex- mone in vitro and in vivo (85) 99 mors by single-strand conformation poly- pression of the OVCA 433 ovarian cancer Gavish, M., Bar-Ami, S. and Weizman, R. morphism (SSCP) analysis (87) 125 cells (83) 183 The endocrine system and mitochondrial Dufaure, J.P., see Rigaudiére, N. (89) 67 Ferrara, P., see Oke, B.O. (87) R1 benzodiazepine receptors (88) 1 Dumont, J.E., see Esteves, R.Z. (90) R1 Fiddes, R.J., Brandon, M.R. and Adams, T.E. Genuardi, M., see Ferrandina, G. (83) 183 Dumont, J.E., see Van Sande, J. (88) R1 Functional expression of an ovine growth Geraerts, W.P.M., see Li, K.W. (85) 141 Duval, J., see Anouar, Y. (88) 97 hormone receptor in transfected Chinese Gertler, A., see Sakal, E. (90) 39 hamster ovary cells (86) 37 Gervy-Decoster, C., see Donda, A. (90) R23 Fiebig, S., Schmitt-Wrede, H.-P., Wunderlich, Gherzi, R., see Sesti, G. (86) 111 Ebberink, R.H.M., see Li, K.W. (85) 141 F., Stangier, J. and Schiltz, E. Ghilchik, M.W., see Singh, A. (83) 85 Eby, J.E., see Sato, H. (83) 239 Testosterone-induced diminution of two Ghyselinck, N.B., see Rigaudiére, N. (89) 67 Egozi, Y., see Koren, D. (90) 87 peptides in spleen cells from testosterone- Giat, J., see Segal-Abramson, T. (85) 109 Eidne, K.A., Sellar, R.E., Couper, G., Ander- immunosuppressed B10 mice (84) R27 Gibbs, R.B., see Okano, H.J. (87) 179 son, L. and Taylor, P.L. Finke, R., Foti, D. and Rapoport, B. Gibori, G., see Nelson, S.E. (85) 195 Molecular cloning and characterisation of Importance of the carboxyl terminus of Gilbert, L.I., see Combest, W.L. (83) 11 the rat pituitary gonadotropin-releasing human thyroid peroxidase in the efficient Gilkes, A.F., MacKay, K.B., Cramb, G. and hormone (GnRH) receptor (90) RS expression of the protein in eukaryotic Guild, S.B. Eidne, K.A., see Anderson, L. (86) 167 cells (84) 73 Atrial natriuretic peptide effects in AtT-20 Eisen, C., see Wehling, M. (90) C5 Flinterman, J.F., see Van Haren, L. (87) 57 pituitary tumour cells (89) 39 Ekiko, D.B., see Franklin, R.B. (90) 27 Flynn, T.G., see Roy, R.N. (86) R1 Giordano, G., see Barreca, A. (84) 119 Ekstr6m, T.J., see Levinovitz, A. (89) 105 Flyvbjerg, A., see Pedersen, S.B. (86) 67 Girard, D.M., see Emanuel, R.L. (86) 29 Ellerkmann, E., see Porter, T.E. (84) 23 Foti, D., see Finke, R. (84) 73 Girbau, M., Gonzalez-Guerrero, P.R., Bassas, Emanuel, R.L., Girard, D.M., Thull, D.L. and Franklin, R.B., Ekiko, D.B. and Costello, L.C. L. and De Pablo, F. Majzoub, J.A. Prolactin stimulates transcription of aspar- Insulin receptors and insulin-like growth Regulated expression of vasopressin gene tate aminotransferase in prostate cells (90) factor I receptors in embryos from gas- by cAMP and phorbol ester in primary rat 27 trula until organogenesis (90) 69 fetal hypothalamic cultures (86) 29 Franks, D.J., see Simboli-Campbell, M. (83) Giroix, M.-H., Rasschaert, J., Sener, A., Engelhardt, H., Tekpetey, F.R., Gore-Lang- 143 Leclercq-Meyer, V., Bailbe, D., Portha, B. ton, R.E. and Armstrong, D.T. Franks, S., see Mason, H.D. (89) R1 and Malaisse, W.J. Regulation of steroid production in cul- Frawley, L.S., see Porter, T.E. (84) 23 Study of hexose transport, glycerol phos- tured porcine thecal cells by transforming Freshney, M., see Bond, J.A. (84) R15 phate shuttle and Krebs cycle in islets of growth factor-B (85) 117 Friesen, H.G., see Sterba, T. (90) 179 adult rats injected with streptozotocin dur- Engler, D., see Liu, J.-P. (87) 35 Friesen, H.G., see Wagner, G.F. (90) 7 ing the neonatal period (83) 95 Enright, W.J., see Spicer, L.J. (83) 73 Frunzio, R., see Veneziani, B.M. (86) 11 Gitay-Goren, H., see Bar-Ami, S. (90) 157 228 Goberna, R., see Sanchez-Margalet, V. (88) Harlan, R., see Krozowski, Z. (85) 21 Ovarian follicular atresia as an apoptotic 129 Hatey, F., Langlois, I., Mulsant, P., Bonnet, process: a paradigm for programmed cell Goforth, D.P., see Murono, E.P. (88) 39 A., Benne, F. and Gasser, F. death in endocrine tissues (84) C19 Gogiia, F., see Lanni, A. (86) 143 Gonadotropins induce accumulation of in- Huxham, G.J., see Armstrong, J.W. (88) 105 Goke, B., see Fehmann, H.-C. (85) C39 sulin-like growth factor I mRNA in pig Goke, R., see Fehmann, H.-C. (85) C39 granulosa cells in vitro (86) 205 Imura, H., see Sasaki, S. (84) 159 Gonzalez-Cadavid, N.F., Vernet, D., Hattori, M.-a. and Horiuchi, R. Inouye, S., Ling, N. and Shimasaki, S. Fuentes Navarro, A., Rodriguez, J.A., Biphasic effects of exogenous ganglioside Localization of the heparin binding site of Swerdloff, R.S. and Rajfer, J. GM3 on follicle-stimulating hormone-de- follistatin (90) 1 Up-regulation of the levels of androgen pendent expression of luteinizing hormone Inukai, T., Wang, X. and Greer, M.A. receptor and its mRNA by androgens in receptor in cultured granulosa cells (88) 47 a-Adrenergic inhibition of thyrotropin-re- smooth-muscle cells from rat penis (90) Haux, C., see Le Goff, P. (90) 133 leasing hormone-induced prolactin secre- 219 Hawes, B.E., see Conn, P.M. (84) C33 tion in GH,C;, cells is associated with a Gonzalez-Guerrero, P.R., see Girbau, M. (90) Hedger, M.P., see Risbridger, G.P. (83) 125 depressed rise in intracellular Ca** (87) 69 Hedger, M.P., see Simpson, B.J.B. (87) 167 29 Gordon, D.F., see Wierman, M.E. (86) 1 Hellman, P., see Ridefelt, P. (83) 211 Isales, C.M., see Bollag, W.B. (86) 93 Gore-Langton, R.E., see Engelhardt, H. (85) Hennen, G., see Reiter, E. (88) 77 Ivell, R., Hunt, N., Hardy, M., Nicholson, H. 117 Herington, A.C., see Albiston, A.L. (83) R17 and Pickering, B. Goto, H., see Wiese, R.J. (90) 197 Herington, A.C., see Tiong, T.S. (83) 133 Vasopressin biosynthesi: in rodent Leydig Gout, I., see Harfst, E. (83) 117 Herington, A.C., see Ymer, S.I. (83) 39 cells (89) 59 Graham, G.J., see Bond, J.A. (84) R15 Herrmann, H.-D., see Puchner, M.J.A. (85) Granger, N.A., see Allen, C.U. (84) 227 157 Grasso, P. and Reichert, Jr., L.E. Hertelendy, F., Molnar, M. and Jamaluddin, Jamaluddin, M., see Hertelendy, F. (83) 173 Stabilization of follicle-stimulating hor- M. Jannini, E.A., see Ulisse, S. (87) 131 mone-receptor complexes may involve cal- Dual action of arachidonic acid on cal- Janovick, J.A., see Conn, P.M. (84) C33 cium-dependent transglutaminase activa- cium mobilization in avian granulosa cells Jansson, L., see Sandler, S. (86) 149 tion (87) 49 (83) 173 Janzen, W.P., see Allen, C.U. (84) 227 Gravel, R.A., see Drews, R.T. (87) 125 Heyns, W., see De Vos, P. (90) R11 Jaussi, R., Watson, G. and Paigen, K. Greenberg, R.M., see Lin, Y.-W.P. (85) 127 Heyns, W., see Mariveet, S. (88) 165 Modulation of androgen-responsive gene Greer, M.A., see Inukai, T. (87) 29 HOflich, M., see Zink, A. (86) 213 expression by estrogen (86) 187 Greer, M.A., see Sato, N. (86) 137 Holloway, B.R., see Champigny, O. (86) 73 Javaux, F., see Christophe-Hobertus, C. (88) Greer, M.A., see Wang, X. (83) 79 Holly, J.M.P., see Mason, H.D. (89) R1 31 Greer, M.A., see Wang, X. (87) 157 Holmgren, A., see Padilla, C.A. (85) 1 Javaux, F., see Donda, A. (90) R23 Grima, J., Pineau, C., Bardin, C.W. and Holthuizen, P.E., see Van Dijk, M.A. (88) 175 Jeung, E.B., see Krisinger, J. (86) 119 Cheng, C.Y. Hoogasian, J., see Jonassen, J.A. (84) 55 Jeung, E.B., see Krisinger, J. (88) 119 Rat Sertoli cell clusterin, a -macroglobu- Hoogerbrugge, J.W., see Blok, L.J. (88) 153 Jiang, L.G., see Sairam, M.R. (85) 227 lin, and testins: biosynthesis and differen- Hoogerbrugge, J.W., see De Winter, J.P. (83) Jiang, S.-Y., Wolf, D.M., Yingling, J.M., tial regulation by germ cells (89) 127 R1 Chang, C. and Jordan, V.C. Gromoll, J., see Kliesch, S. (84) R45 Horiuchi, R., see Hattori, M.-a. (88) 47 An estrogen receptor positive MCF-7 Gronbek, H., see Pedersen, S.B. (86) 67 Hornsby, P.J., see Lala, D.S. (89) 19 clone that is resistant to antiestrogens and Groner, I., see McArdle, C.A. (87) 95 Houdebine, L.M., see Pierre, S. (87) 147 estradiol (90) 77 Grootegoed, J.A., see Blok, L.J. (88) 153 Hoyland, J., see Anderson, L. (86) 167 Johnson, M.J., see Eyster, K.M. (86) 125 Grootegoed, J.A., see De Winter, J.P. (83) R1 Hrachovy, J.A., see Schwarz, L.A. (86) 103 Johnson, M.S., Mitchell, R. and Thomson, Grootegoed, J.A., see Klaij, I.A. (85) 237 Hu, R.M., Sakurai, A., Miyamoto, T. and FJ. Grootenhuis, A.J., see De Winter, J.P. (83) DeGroot, L.J. The priming effect of luteinizing hor- 105 Expression and function of a human thy- mone-releasing hormone (LHRH) but not Gross, D.J., see Wentworth, B.M. (86) 177 roid hormone receptor-derived DNA- LHRH-induced gonadotropin release, can Gruber, J.A., see Roehrborn, C.G. (84) 1 binding domain protein (84) 209 be prevented by certain protein kinase C Gudermann, T., see Nieschlag, E. (87) R25 Huang, J., Ujihara, M., Xia, H., Chen, F., inhibitors (85) 183 Guild, S.B., see Gilkes, A.F. (89) 39 Yoshida, H. and Puett, D. Johnstone, A.P., see Harfst, E. (83) 117 Guillou, M.D., Barre, N., Bussenot, L., Mutagenesis of the ‘determinant loop’ re- Jolivet, G., see Pierre, S. (87) 147 Plevrakis, I. and Clamagirand, C. gion of human choriogonadotropin B (90) Jonassen, J.A., Mullikin-Kilpatrick, D.., COOH-terminally-extended processing 211 Hoogasian, J., Benoit, S.E. and Leeman, forms of oxytocin in human ovary (83) 233 Hugel, H.M., see Kennaway, D.J. (88) Cl SE. Gunsalus, G.L., see Porto, C.S. (89) 33 Huhtaniemi, I.T., Eskola, V., Pakarinen, P., Regulation of adenohypophyseal messen- Gylfe, E., see Ridefelt, P. (83) 211 Matikainen, T. and Sprengel, R. ger RNAs in female rats by age, hypothy- The murine luteinizing hormone and folli- roidism, estradiol and neonatal androge- cle-stimulating hormone receptor genes: nization (84) 55 Halban, P.A., see Wentworth, B.M. (86) 177 transcription initiation sites, putative pro- Jones, L.S., Ottobre, J.S. and Pate, J.L. Hall, P.F., see Brown, A.S. (83) 1 moter sequences and promoter activity (88) Progesterone regulation of luteinizing hor- Hardy, M., see Ivell, R. (89) 59 55 mone receptors on cultured bovine luteal Harfst, E., Johnstone, A.P., Gout, I., Taylor, Hunt, N., see Ivell, R. (89) 59 cells (85) 33 A.H., Waterfield, M.D. and Nussey, S.S. Hunzicker-Dunn, M., see DeManno, D.A. Joosse, J., see Li, K.W. (85) 141 The use of the amplifiable high-expression (86) 157 Jordan, V.C., see Jiang, S.-Y. (90) 77 vector pEE14 to study the interactions of Hunzicker-Dunn, M., see Nelson, S.E. (85) Jouvenot, M., see Pellerin, I. (90) R17 autoantibodies with recombinant human 195 Jouvenot, M., see Vuillermoz, C. (87) R11 thyrotrophin receptor (83) 117 Hurwitz, A. and Adashi, E.Y. Jump, D.B., see Lepar, G.J. (84) 65